General Information of Drug (ID: DM4RXDQ)

Drug Name
ISIS-HBV Drug Info
Indication
Disease Entry ICD 11 Status REF
Hepatitis B virus infection 1E51.0 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM4RXDQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AB-729 DM48DPS Hepatitis B virus infection 1E51.0 Phase 2 [3]
ARO-HBV DM76S3X Hepatitis B 1E51 Phase 1/2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hepatitis B virus messenger RNA (HBV mRNA) TT43YWN NOUNIPROTAC Not Available [2]

References

1 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.
3 Clinical pipeline report, company report or official report of Arbutus Biopharma.
4 Clinical pipeline report, company report or official report of Arrowhead Pharmaceuticals.